Updates are available Correction dated 2020-09-07
Click to view Correction: https://doi.org/10.1038/s41573-020-0085-5
-
Authors
Sgouros, George https://orcid.org/0000-0002-4553-2866
Bodei, Lisa https://orcid.org/0000-0001-6930-7383
McDevitt, Michael R.
Nedrow, Jessie R. https://orcid.org/0000-0002-3465-1296
- License Information
-
More Information
Article History
Accepted: 8 June 2020
First Online: 29 July 2020
Change Date: 7 September 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41573-020-0085-5
Competing interests
: G.S. is a founder of and holds equity in Radiopharmaceutical Imaging and Dosimetry LLC (Rapid). He serves as a member of Rapid’s Board of Directors; this arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies. M.M. was a consultant for Actinium Pharmaceuticals, Regeneron, Progenics, Bridge Medicine and General Electric. Memorial Sloan Kettering has filed for IP protection for inventions of M.M. related to alpha particle technology. L.B. was a non-paid consultant for Advanced Accelerator Applications (AAA), Ipsen, Clovis, ITM and Curium, and receives research support from AAA. Johns Hopkins University has filed for IP protection for inventions of J.N. related to alpha particle technology.
